Search Results - "Licht, Ruud"
-
1
Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering
Published in Journal of orthopaedic research (01-08-2007)“…The use of multipotent human mesenchymal stem cells (hMSCs) for tissue engineering has been a subject of extensive research. The donor variation in growth,…”
Get full text
Journal Article -
2
Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds
Published in Biomaterials (01-10-2006)“…Electrospinning (ESP) has lately shown a great potential as a novel scaffold fabrication technique for tissue engineering. Scaffolds are produced by spinning a…”
Get full text
Journal Article -
3
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo
Published in Proceedings of the National Academy of Sciences - PNAS (20-05-2008)“…Tissue engineering of large bone defects is approached through implantation of autologous osteogenic cells, generally referred to as multipotent stromal cells…”
Get full text
Journal Article -
4
Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1
Published in Biomaterials (01-06-2013)“…Abstract Mesenchymal stromal cells (hMSCs) are advancing into the clinic but the therapeutic efficacy of hMSCs faces the problem of donor variability. In bone…”
Get full text
Journal Article -
5
Canonical Wnt signaling in the notochordal cell is upregulated in early intervertebral disk degeneration
Published in Journal of orthopaedic research (01-06-2012)“…The notochordal cell (NC) of the nucleus pulposus (NP) is considered a potential NP progenitor cell, and early intervertebral disk (IVD) degeneration involves…”
Get full text
Journal Article -
6
Applicability of a Newly Developed Bioassay for Determining Bioactivity of Anti-Inflammatory Compounds in Release Studies − Celecoxib and Triamcinolone Acetonide Released from Novel PLGA-Based Microspheres
Published in Pharmaceutical research (01-02-2015)“…Purpose : To develop a bio-assay for measuring long-term bioactivity of released anti-inflammatory compounds and to test the bioactivity of celecoxib (CXB) and…”
Get full text
Journal Article -
7
Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells
Published in European journal of pharmaceutical sciences (12-03-2014)“…[Display omitted] The application of RNA interference (RNAi) has great therapeutic potential for degenerative diseases of cartilaginous tissues by means of…”
Get full text
Journal Article -
8
The effect of PKC activation and inhibition on osteogenic differentiation of human mesenchymal stem cells
Published in Journal of tissue engineering and regenerative medicine (01-07-2010)“…Human mesenchymal stem cells (hMSCs) are being considered for several areas of clinical therapy, due to their multipotent nature. For instance, osteogenic…”
Get full text
Journal Article -
9
The Effect of a Cyclooxygenase 2 Inhibitor on Early Degenerated Human Nucleus Pulposus Explants
Published in Global spine journal (01-02-2014)“…Study Design Preclinical in vitro culture of human degenerated nucleus pulposus (NP) tissue. Objective Cyclooxygenase 2 inhibitors (e.g., celecoxib) inhibit…”
Get full text
Journal Article -
10
Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis
Published in Current opinion in nephrology and hypertension (01-05-1999)“…The cardinal feature of systemic lupus erythematosus is the formation of anti-nuclear antibodies. In recent years, it has become clear that the nucleosome is a…”
Get full text
Journal Article -
11
Inhibition of histone acetylation as a tool in bone tissue engineering
Published in Tissue engineering (01-10-2006)“…Our approach to bone tissue engineering is the in vitro expansion and osteogenic differentiation of bone marrow-derived human mesenchymal stem cells (hMSCs)…”
Get more information
Journal Article